These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34043368)

  • 1. Serum Bile Acid Profiles Improve Clinical Prediction of Nonalcoholic Fatty Liver in T2DM patients.
    Wu T; Yang M; Xu H; Wang L; Wei H; Ji G
    J Proteome Res; 2021 Aug; 20(8):3814-3825. PubMed ID: 34043368
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of Serum Bile Acid and Unsaturated Fatty Acid Profiles with the Risk of Diabetic Retinopathy in Type 2 Diabetic Patients.
    Feng S; Guo L; Wang S; Chen L; Chang H; Hang B; Mao J; Snijders AM; Lu Y; Ding D
    Diabetes Metab Syndr Obes; 2023; 16():2117-2128. PubMed ID: 37465650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes.
    Brouwers B; Schrauwen-Hinderling VB; Jelenik T; Gemmink A; Havekes B; Bruls Y; Dahlmans D; Roden M; Hesselink MKC; Schrauwen P
    Clin Sci (Lond); 2017 Aug; 131(15):1905-1917. PubMed ID: 28620012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis.
    Liu X; Wang Y; Ming Y; Song Y; Zhang J; Chen X; Zeng M; Mao Y
    PLoS One; 2015; 10(5):e0127352. PubMed ID: 25993652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The significance of 8-hydroxy-deoxyguanosine acid in the diagnosis of nonalcoholic steatohepatitis].
    Jiang Y; Han T; Zhang ZG; Lu SQ; Mi YQ; Xu L; Qi FX; Zhang Y; Song GD
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):34-38. PubMed ID: 28056321
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating Bile Acids as Biomarkers for Disease Diagnosis and Prevention.
    Qi L; Chen Y
    J Clin Endocrinol Metab; 2023 Jan; 108(2):251-270. PubMed ID: 36374935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum bile acid and unsaturated fatty acid profiles of non-alcoholic fatty liver disease in type 2 diabetic patients.
    Feng SS; Wang SJ; Guo L; Ma PP; Ye XL; Pan ML; Hang B; Mao JH; Snijders AM; Lu YB; Ding DF
    World J Diabetes; 2024 May; 15(5):898-913. PubMed ID: 38766436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAFL screening score: A basic score identifying ultrasound-diagnosed non-alcoholic fatty liver.
    Zhou YJ; Zhou YF; Zheng JN; Liu WY; Van Poucke S; Zou TT; Zhang DC; Shen S; Shi KQ; Wang XD; Zheng MH
    Clin Chim Acta; 2017 Dec; 475():44-50. PubMed ID: 28964832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NAFL Risk Score: A simple scoring model to predict 4-y risk for non-alcoholic fatty liver.
    Zhou YJ; Zheng JN; Liu WY; Miele L; Vitale A; Van Poucke S; Zou TT; Fang DH; Shen S; Zhang DC; Zheng MH
    Clin Chim Acta; 2017 May; 468():17-24. PubMed ID: 28111272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty liver index as a simple predictor of incident diabetes from the KoGES-ARIRANG study.
    Yadav D; Choi E; Ahn SV; Koh SB; Sung KC; Kim JY; Huh JH
    Medicine (Baltimore); 2016 Aug; 95(31):e4447. PubMed ID: 27495073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease.
    Aida Y; Abe H; Tomita Y; Nagano T; Seki N; Sugita T; Itagaki M; Ishiguro H; Sutoh S; Aizawa Y
    Int J Clin Exp Med; 2014; 7(11):4191-8. PubMed ID: 25550930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The aggravation of mitochondrial dysfunction in nonalcoholic fatty liver disease accompanied with type 2 diabetes mellitus.
    Liu X; Zhang J; Ming Y; Chen X; Zeng M; Mao Y
    Scand J Gastroenterol; 2015; 50(9):1152-9. PubMed ID: 25877002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans.
    Lee JW; Lim NK; Park HY
    BMC Endocr Disord; 2018 May; 18(1):33. PubMed ID: 29843706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts.
    Mayo R; Crespo J; Martínez-Arranz I; Banales JM; Arias M; Mincholé I; Aller de la Fuente R; Jimenez-Agüero R; Alonso C; de Luis DA; Vitek L; Stritesky J; Caballería J; Romero-Gómez M; Martín-Duce A; Mugüerza Huguet JM; Busteros-Moraza JI; Idowu MO; Castro A; Martínez-Chantar ML; Ortiz P; Bruha R; Lu SC; Bedossa P; Noureddin M; Sanyal AJ; Mato JM
    Hepatol Commun; 2018 Jul; 2(7):807-820. PubMed ID: 30027139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
    Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH
    World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver.
    Lehmann R; Franken H; Dammeier S; Rosenbaum L; Kantartzis K; Peter A; Zell A; Adam P; Li J; Xu G; Königsrainer A; Machann J; Schick F; Hrabé de Angelis M; Schwab M; Staiger H; Schleicher E; Gastaldelli A; Fritsche A; Häring HU; Stefan N
    Diabetes Care; 2013 Aug; 36(8):2331-8. PubMed ID: 23514731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The urinary bile acid profiling analysis of asymptomatic hypercholanemia of pregnancy: A pseudo-targeted metabolomics study.
    Chen X; Zhang X; Xu B; Cui Y; He Y; Yang T; Shao Y; Ding M
    Clin Chim Acta; 2019 Oct; 497():67-75. PubMed ID: 31276634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Differential Metabolites Between 
Type 2 Diabetes and Postchronic Pancreatitis Diabetes (Type 3c) Based on an Untargeted Metabolomics Approach.
    Qi L; Ye Z; Lin H
    Lab Med; 2023 Nov; 54(6):562-573. PubMed ID: 36864551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.